Market Research Logo

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Electrophysiology Devices - Medical Devices Pipeline Assessment, 2018 provides an overview of Electrophysiology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Electrophysiology Devices Overview
3 Products under Development
3.1 Electrophysiology Devices - Pipeline Products by Stage of Development
3.2 Electrophysiology Devices - Pipeline Products by Segment
3.3 Electrophysiology Devices - Pipeline Products by Territory
3.4 Electrophysiology Devices - Pipeline Products by Regulatory Path
3.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date
3.6 Electrophysiology Devices - Ongoing Clinical Trials
4 Electrophysiology Devices - Pipeline Products under Development by Companies
4.1 Electrophysiology Devices Companies - Pipeline Products by Stage of Development
4.2 Electrophysiology Devices - Pipeline Products by Stage of Development
5 Electrophysiology Devices Companies and Product Overview
5.1 Ablacon Inc Company Overview
5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Cardiac Therapeutics, Inc. Company Overview
5.2.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Apama Medical, Inc. Company Overview
5.3.1 Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 AtriCure Inc Company Overview
5.4.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Aust Development, LLC Company Overview
5.5.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 Baylor College of Medicine Company Overview
5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.7 Ben-Gurion University of the Negev Company Overview
5.7.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
5.8 Berlin Heals GmbH Company Overview
5.8.1 Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.9 Biosense Webster Inc Company Overview
5.9.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 BioSig Technologies Inc Company Overview
5.10.1 BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 BioTex Inc Company Overview
5.11.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Boston Scientific Corp Company Overview
5.12.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 Cardima, Inc. (Inactive) Company Overview
5.13.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 CardioFocus Inc Company Overview
5.14.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 CardioNova Ltd Company Overview
5.15.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 CathEffects LLC Company Overview
5.16.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 CathRx Ltd Company Overview
5.17.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 CathVision Aps Company Overview
5.18.1 CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview
5.19 Cibiem Inc Company Overview
5.19.1 Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Columbia University Company Overview
5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.21 Cordis Corp Company Overview
5.21.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.22 CoRepair, Inc Company Overview
5.22.1 CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 CryoTherapeutics Gmbh Company Overview
5.23.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview
5.24 CyberHeart Inc Company Overview
5.24.1 CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 EP Dynamics, Inc. Company Overview
5.25.1 EP Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.26 EP Solutions SA Company Overview
5.26.1 EP Solutions SA Pipeline Products & Ongoing Clinical Trials Overview
5.27 EPD Solutions Ltd Company Overview
5.27.1 EPD Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 Epicardial Technologies Inc (Inactive) Company Overview
5.28.1 Epicardial Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.29 FocusStart LLC Company Overview
5.29.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
5.30 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview
5.30.1 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview
5.31 Genetesis LLC Company Overview
5.31.1 Genetesis LLC Pipeline Products & Ongoing Clinical Trials Overview
5.32 Hansen Medical Inc Company Overview
5.32.1 Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Imricor Medical Systems Inc Company Overview
5.33.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Interventional Imaging, Inc. Company Overview
5.34.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.35 Iowa Approach Inc. Company Overview
5.35.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.36 Johns Hopkins University Company Overview
5.36.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.37 King's College London Company Overview
5.37.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview
5.38 Maestro Heart SA Company Overview
5.38.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview
5.39 Mayo Clinic Company Overview
5.39.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.40 MC10 Inc Company Overview
5.40.1 MC10 Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 Medlumics SL Company Overview
5.41.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview
5.42 Medtronic plc Company Overview
5.42.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.43 MedWaves Inc Company Overview
5.43.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 MicroPort Scientific Corp Company Overview
5.44.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.45 MRI Interventions Inc Company Overview
5.45.1 MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.46 North Carolina State University Company Overview
5.46.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
5.47 Northwestern University Company Overview
5.47.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.48 Philips Healthcare Company Overview
5.48.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
5.49 SCR, Inc. Company Overview
5.49.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.50 Seattle Children's Hospital Company Overview
5.50.1 Seattle Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.51 Sotera Medical Corp Company Overview
5.51.1 Sotera Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.52 St. Jude Medical LLC Company Overview
5.52.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.53 Stereotaxis Inc Company Overview
5.53.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview
5.54 Strategic Polymer Sciences, Inc Company Overview
5.54.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.55 University of Maryland Company Overview
5.55.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview
5.56 University of Michigan Company Overview
5.56.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.57 University of Rochester Company Overview
5.57.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.58 University of Texas Medical Branch at Galveston Company Overview
5.58.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.59 Vanderbilt University Company Overview
5.59.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
5.60 Vimecon GmbH Company Overview
5.60.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.61 Viscardia Inc Company Overview
5.61.1 Viscardia Inc Pipeline Products & Ongoing Clinical Trials Overview
5.62 Vivonics, Inc. Company Overview
5.62.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.63 Voyage Medical (Inactive) Company Overview
5.63.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6 Electrophysiology Devices- Recent Developments
6.1 Apr 13, 2018: LKC Technologies Partners with US Retina in GPO Program
6.2 Apr 11, 2018: Stereotaxis Announces Expanded European Labeling for Navigation in the Pericardial Space
6.3 Apr 09, 2018: Fischer Medical Receives U.S. FDA 510(k) Clearance to Market Bloom2 Cardiac Stimulator
6.4 Apr 06, 2018: BioSig Technologies to Present at the MicroCap Conference
6.5 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.6 Mar 29, 2018: MicroPort EP Attends the 10th VAS-CHINA
6.7 Mar 28, 2018: BioSig Announces Submission of FDA 510(k) Application for PURE EP System
6.8 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.9 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.10 Mar 19, 2018: Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
6.11 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales
6.12 Mar 15, 2018: ADANI will exhibit medical X-ray equipment at CMEF 2018
6.13 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results
6.14 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results
6.15 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board
6.16 Feb 27, 2018: Ogden Regional Medical Center Earns Echocardiography Accreditation
6.17 Feb 26, 2018: CardioFocus Announces Initiation of HeartLight X3 Clinical Evaluation
6.18 Feb 26, 2018: EPD Obtains European Regulatory Approval for Its Cardiac Mapping and Navigation System
6.19 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
6.20 Feb 23, 2018: Atrial fibrillation patients benefit most from this treatment
6.21 Feb 22, 2018: BioSig Technologies to Partner with Focus Marketing
6.22 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017
6.23 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives
6.24 Feb 21, 2018: ADANI will exhibit its solutions at ECR 2018
6.25 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
6.26 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017
6.27 Feb 19, 2018: Experimentica Names Dr. Marc Cerrada-Gimenez As new Director For In Vivo Pharmacology
6.28 Feb 14, 2018: Uscom: Appendix 4D Results and Update
6.29 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors
6.30 Feb 08, 2018: MicroPort EP Attends 2018 Dunhuang Cardiovascular Disease Forum to Display Columbus
6.31 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology
6.32 Feb 07, 2018: Soren Friis Appointed Director of Global Customer Relations at Nanion
6.33 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017
6.34 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.35 Jan 31, 2018: First Triojection Cases in Germany were Recently Completed by Prof. Dr. Thomas Vogl MD
6.36 Jan 31, 2018: Allegheny Health Network Neurosurgeons First in Region to Provide New Treatment for Painful Spinal Tumors
6.37 Jan 31, 2018: Uscom: Appendix 4C Results and Update Quarter ended 31 December 2017
6.38 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.39 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics
6.40 Jan 29, 2018: ADANI Participates In Arab Health Exhibition 2018
6.41 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move
6.42 Jan 09, 2018: Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations
6.43 Jan 09, 2018: MicroPort Selected as 2017 China Innovative Medical Device Company
6.44 Jan 09, 2018: MicroPort Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation
6.45 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.46 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
6.47 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results
6.48 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory
6.49 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Electrophysiology Devices - Pipeline Products by Stage of Development
Table 2: Electrophysiology Devices - Pipeline Products by Segment
Table 3: Electrophysiology Devices - Pipeline Products by Territory
Table 4: Electrophysiology Devices - Pipeline Products by Regulatory Path
Table 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date
Table 6: Electrophysiology Devices - Ongoing Clinical Trials
Table 7: Electrophysiology Devices Companies - Pipeline Products by Stage of Development
Table 8: Electrophysiology Devices - Pipeline Products by Stage of Development
Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Ablasense - Product Status
Table 11: Ablasense - Product Description
Table 12: Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ACT Cardiac Ablation Catheter - Product Status
Table 14: ACT Cardiac Ablation Catheter - Product Description
Table 15: Advanced Cardiac Therapeutics, Inc. - Ongoing Clinical Trials Overview
Table 16: ACT Cardiac Ablation Catheter - A Randomized Controlled Clinical Evaluation of the DiamondTemp System for the Treatment of Paroxysmal Atrial Fibrillation
Table 17: ACT Cardiac Ablation Catheter - Advanced Cardiac Therapeutics DiamondTemp Temperature-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation
Table 18: Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Apama Ablation Catheter - Product Status
Table 20: Apama Ablation Catheter - Product Description
Table 21: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Next Generation RF Generator - Product Status
Table 23: Next Generation RF Generator - Product Description
Table 24: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Endovascular Cardiac Optical Mapping Device - Product Status
Table 26: Endovascular Cardiac Optical Mapping Device - Product Description
Table 27: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Catheter-Based Electrophysiological Imaging System - Product Status
Table 29: Catheter-Based Electrophysiological Imaging System - Product Description
Table 30: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Excitation Wave Cancellation Device - Product Status
Table 32: Excitation Wave Cancellation Device - Product Description
Table 33: Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Berlin Heals Cardiac Microcurrent Therapy Device - Product Status
Table 35: Berlin Heals Cardiac Microcurrent Therapy Device - Product Description
Table 36: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Balloon Catheter - Atrial Fibrillation - Product Status
Table 38: Balloon Catheter - Atrial Fibrillation - Product Description
Table 39: CARTO 4 - Product Status
Table 40: CARTO 4 - Product Description
Table 41: CARTO SMARTTOUCH 5D Catheter - Product Status
Table 42: CARTO SMARTTOUCH 5D Catheter - Product Description
Table 43: Next Generation Ablation Catheter - Product Status
Table 44: Next Generation Ablation Catheter - Product Description
Table 45: nMARQ Pulmonary Vein Isolation System - Product Status
Table 46: nMARQ Pulmonary Vein Isolation System - Product Description
Table 47: Biosense Webster Inc - Ongoing Clinical Trials Overview
Table 48: nMARQ Pulmonary Vein Isolation System - Pulmonary Veins Circular Ablation Catheter Evaluation for Atrial Fibrillation
Table 49: BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: PURE EP System - Product Status
Table 51: PURE EP System - Product Description
Table 52: PURE EP Version 2.0 - Product Status
Table 53: PURE EP Version 2.0 - Product Description
Table 54: PURE EP Version 3.0 - Product Status
Table 55: PURE EP Version 3.0 - Product Description
Table 56: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Cooled Tip Catheter - Product Status
Table 58: Cooled Tip Catheter - Product Description
Table 59: Water-cooled Catheter - Product Status
Table 60: Water-cooled Catheter - Product Description
Table 61: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Cryo Balloon Catheter - Product Status
Table 63: Cryo Balloon Catheter - Product Description
Table 64: DirectSense Rx Catheter - Product Status
Table 65: DirectSense Rx Catheter - Product Description
Table 66: Force Sensing Afib Catheter - Product Status
Table 67: Force Sensing Afib Catheter - Product Description
Table 68: IntellaNav MiFi OI AF Ablation Catheter - Product Status
Table 69: IntellaNav MiFi OI AF Ablation Catheter - Product Description
Table 70: LabSystem PRO NextGen - Product Status
Table 71: LabSystem PRO NextGen - Product Description
Table 72: Lesion Assessment Device - Product Status
Table 73: Lesion Assessment Device - Product Description
Table 74: Next Generation Blazer Catheter - Product Status
Table 75: Next Generation Blazer Catheter - Product Description
Table 76: Next Generation IntellaTip Catheter - Product Status
Table 77: Next Generation IntellaTip Catheter - Product Description
Table 78: OI System - Product Status
Table 79: OI System - Product Description
Table 80: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 81: Next Generation IntellaTip Catheter - Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success
Table 82: IntellaNav MiFi OI AF Ablation Catheter - Electrical Coupling Information from the Rhythmia HDx Mapping System and Direct Sense Technology in the Treatment of Paroxysmal Atrial Fibrillation - A Non-randomized, Prospective Study
Table 83: Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 84: CADENCE EPL - Product Status
Table 85: CADENCE EPL - Product Description
Table 86: EP Ablation System - Product Status
Table 87: EP Ablation System - Product Description
Table 88: CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 89: HeartLight Excalibur Balloon - Product Status
Table 90: HeartLight Excalibur Balloon - Product Description
Table 91: HeartLight X3 System - Product Status
Table 92: HeartLight X3 System - Product Description
Table 93: CardioFocus Inc - Ongoing Clinical Trials Overview
Table 94: HeartLight Excalibur Balloon - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation
Table 95: HeartLight X3 System - Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) with Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation
Table 96: CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Electrophysiology Catheter - Atrial Fibrillation - Product Status
Table 98: Electrophysiology Catheter - Atrial Fibrillation - Product Description
Table 99: CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Status
Table 101: Desai VectorCathRF1 Mapping And Ablation Catheter - Product Description
Table 102: CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 103: CathRx 4mm Therapeutic Catheter - Product Status
Table 104: CathRx 4mm Therapeutic Catheter - Product Description
Table 105: CathRx 8mm Therapeutic Catheter - Product Status
Table 106: CathRx 8mm Therapeutic Catheter - Product Description
Table 107: Khelix Fixed Catheter - Product Status
Table 108: Khelix Fixed Catheter - Product Description
Table 109: Khelix Fixed Loop EP Catheter - Product Status
Table 110: Khelix Fixed Loop EP Catheter - Product Description
Table 111: Khelix Fixed Loop Steerable EP Catheter - Product Status
Table 112: Khelix Fixed Loop Steerable EP Catheter - Product Description
Table 113: Khelix Irrigated Ablation EP Catheter - Product Status
Table 114: Khelix Irrigated Ablation EP Catheter - Product Description
Table 115: Khelix Non-Irrigated Ablation EP Catheter - Product Status
Table 116: Khelix Non-Irrigated Ablation EP Catheter - Product Description
Table 117: Khelix Steerable Catheter - Product Status
Table 118: Khelix Steerable Catheter - Product Description
Table 119: Khelix Variable Loop Steerable EP Catheter - Product Status
Table 120: Khelix Variable Loop Steerable EP Catheter - Product Description
Table 121: CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview
Table 122: CathVision Cube - Product Status
Table 123: CathVision Cube - Product Description
Table 124: Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Catheter-Based Carotid Body Ablation System - Product Status
Table 126: Catheter-Based Carotid Body Ablation System - Product Description
Table 127: Cibiem Inc - Ongoing Clinical Trials Overview
Table 128: Catheter-Based Carotid Body Ablation System - First-in-human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects with Treatment-resistant Hypertension: A Safety and Feasibility Study
Table 129: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 130: Optically-Integrated RFA Catheter - Product Status
Table 131: Optically-Integrated RFA Catheter - Product Description
Table 132: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 133: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Status
Table 134: EP Contact Force Sensing Catheter Enabled By CARTO 3 - Product Description
Table 135: EP Lesion Assessment Device - Product Status
Table 136: EP Lesion Assessment Device - Product Description
Table 137: CoRepair, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 138: Radiofrequency Device - Product Status
Table 139: Radiofrequency Device - Product Description
Table 140: CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview
Table 141: Cryotherapy System - Coronary Artery Disease - Product Status
Table 142: Cryotherapy System - Coronary Artery Disease - Product Description
Table 143: CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 144: CyberHeart System - Product Status
Table 145: CyberHeart System - Product Description
Table 146: CyberHeart Inc - Ongoing Clinical Trials Overview
Table 147: CyberHeart System - CyberHeart's Cardiac Arrhythmia Ablation Treatment: Patients with Refractory Ventricular Tachycardia
Table 148: EP Dynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 149: EPD D700 System - Product Status
Table 150: EPD D700 System - Product Description
Table 151: EP Dynamics, Inc. - Ongoing Clinical Trials Overview
Table 152: EPD D700 System - Dielectric Unravelling of Radiofrequency Ablation Effectiveness: Durable-I Study
Table 153: EP Solutions SA Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Second Generation AMYCARD System - Product Status
1.2 List of Figures
Figure 1: Electrophysiology Devices - Pipeline Products by Stage of Development
Figure 2: Electrophysiology Devices - Pipeline Products by Segment
Figure 3: Electrophysiology Devices - Pipeline Products by Territory
Figure 4: Electrophysiology Devices - Pipeline Products by Regulatory Path
Figure 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date
Figure 6: Electrophysiology Devices - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report